A combined protocol for this situation might involve starting BPC-157 at 250 mcg twice daily, with subcutaneous injection approximately 1-2 inches lateral to the patellar tendon
The sample population was adults who reported having taken a GLP-1 medication for weight loss
J.YangB
Eligible patients may qualify for Semaglutide, Tirzepatide, GLP-1 weight loss medications, Phentermine, and other prescription weight loss treatments through secure telehealth appointments
However, data from the phase 2 obesity program using slower dose escalations showed additional weight loss benefits of doses up to 2.8 mg/week and a favorable risk-benefit profile for higher doses (16)
The evolutionary advantage this provides is not fully understood but may in part relate to its neuroprotective properties discussed below, although it comes at a substantial cost associated with the incidence of, for example, gout and cardiovascular disease 1